Apposite's Secondary Investments Approach
In parallel to our primary investments, Apposite Capital acquires and manages direct secondary assets in Healthcare. Our secondary activities aim to purchase interests from other venture capital and private equity firms who seek liquidity or wish to restructure their direct investment portfolios.
Apposite has experience in acquiring secondary opportunities and is flexible in structuring such transactions to address all parties’ needs.
Apposite seeks to acquire secondary assets across all sectors within Healthcare - biotech, pharmaceuticals, medtech, diagnostics, healthcare services, medical equipment – globally. We specifically target secondary opportunities where we can take an active role, provide strategic input, and facilitate exit routes.
Apposite's Secondary Portfolio
Apposite's secondary portfolio includes the following companies:
Omniguide Inc.
Location: Cambridge, MA, USA
Website: www.omni-guide.com
OmniGuide designs and manufactures precise optical scalpels using flexible CO2 laser fibres for minimally invasive surgery.
Sotera Wireless Inc.
Location: San Diego, CA, USA
Website: www.soterawireless.com
Sotera Wireless (previously Triage Wireless) is a medical device company dedicated to development, marketing and sale of a new generation of vital signs monitoring technology for both the hospital and the home environment.
Ulthera Inc.
Location: Mesa, AZ, USA
Website: www.ulthera.com
Ulthera develops and markets non invasive cosmetic ultrasound-based medical devices into the medical aesthetic market.
Wellpartner Inc.
Location: Portland, OR, USA
Website: www.wellpartner.com
Wellpartner provides pharmacy distribution solutions for health plans, Medicaid programmes and safety-net organisations throughout the United States.
Zonare Medical Systems Inc.
Location: Mountain View, CA, USA
Website: www.zonare.com
Zonare is a leading provider of premium compact ultrasound systems, providing imaging diagnostic solutions to a wide range of clinical settings.